tiprankstipranks
Advertisement
Advertisement

CYTK Stock Latest News

Cytokinetics launches Myqorzo in Germany
The FlyCytokinetics launches Myqorzo in Germany
4d ago
CYTK
Cytokinetics Shareholders Reinforce Board and Governance Frameworks
PremiumCompany Announcements
Cytokinetics Shareholders Reinforce Board and Governance Frameworks
9d ago
8K
CYTK
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
PremiumMarket News
Citi Names 2 Biotech Stocks ‘Top Picks’ for 2026
12d ago
CYTK
IONS
Cytokinetics Earnings Call Signals Transformational Launch
PremiumCompany Announcements
Cytokinetics Earnings Call Signals Transformational Launch
17d ago
CYTK
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
PremiumThe Fly
StubHub, Jazz Pharmaceuticals upgraded: Wall Street’s top analyst calls
17d ago
AMT
BAP
Cytokinetics initiated with a Buy, named a top pick at Citi
PremiumThe FlyCytokinetics initiated with a Buy, named a top pick at Citi
18d ago
CYTK
Cytokinetics price target raised to $97 from $92 at JPMorgan
Premium
The Fly
Cytokinetics price target raised to $97 from $92 at JPMorgan
24d ago
CYTK
Cytokinetics announces new data related to Myqorzo at ESC Heart Failure 2026
Premium
The Fly
Cytokinetics announces new data related to Myqorzo at ESC Heart Failure 2026
25d ago
CYTK
Cytokinetics price target raised to $140 from $136 at H.C. Wainwright
PremiumThe Fly
Cytokinetics price target raised to $140 from $136 at H.C. Wainwright
25d ago
CYTK
Cytokinetics Raises $760 Million in Stock Offering
PremiumCompany Announcements
Cytokinetics Raises $760 Million in Stock Offering
28d ago
8K
CYTK
Cytokinetics price target raised to $105 from $95 at Wells Fargo
PremiumThe Fly
Cytokinetics price target raised to $105 from $95 at Wells Fargo
29d ago
CYTK
Cytokinetics 9.8M share Secondary priced at $71.00
PremiumThe Fly
Cytokinetics 9.8M share Secondary priced at $71.00
29d ago
CYTK
Cytokinetics price target raised to $108 from $98 at Stifel
PremiumThe FlyCytokinetics price target raised to $108 from $98 at Stifel
29d ago
CYTK
Cytokinetics price target raised to $119 from $101 at RBC Capital
Premium
The Fly
Cytokinetics price target raised to $119 from $101 at RBC Capital
29d ago
CYTK
Cytokinetics price target raised to $103 from $90 at Morgan Stanley
Premium
The Fly
Cytokinetics price target raised to $103 from $90 at Morgan Stanley
29d ago
CYTK
Maxwell Skor Lifts Cytokinetics Price Target to $103 and Reiterates Buy on Strong Phase 3 ACACIA-HCM Results for Aficamten
PremiumRatings
Maxwell Skor Lifts Cytokinetics Price Target to $103 and Reiterates Buy on Strong Phase 3 ACACIA-HCM Results for Aficamten
1M ago
CYTK
Cytokinetics Earnings Call Highlights Launch, Trial Wins
PremiumCompany Announcements
Cytokinetics Earnings Call Highlights Launch, Trial Wins
1M ago
CYTK
Cytokinetics Highlights MYQORZO Progress and Cardiology Pipeline
PremiumCompany Announcements
Cytokinetics Highlights MYQORZO Progress and Cardiology Pipeline
1M ago
8K
CYTK
Analyst Maintains Buy Rating and $136 Price Target on Aficamten Following Strong Phase 3 ACACIA-HCM Results
PremiumRatings
Analyst Maintains Buy Rating and $136 Price Target on Aficamten Following Strong Phase 3 ACACIA-HCM Results
1M ago
CYTK
Morning News Wrap-Up, 5/5/26: Today’s Biggest Stock Market Stories!
PremiumMarket NewsMorning News Wrap-Up, 5/5/26: Today’s Biggest Stock Market Stories!
1M ago
MU
DIA
Cytokinetics price target raised to $106 from $92 at Truist
Premium
The Fly
Cytokinetics price target raised to $106 from $92 at Truist
1M ago
CYTK
Cytokinetics report ‘arguably a best-case scenario’ for Edgewise, says Stifel
Premium
The Fly
Cytokinetics report ‘arguably a best-case scenario’ for Edgewise, says Stifel
1M ago
CYTK
EWTX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >